SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News

1st Stem Cell Community day in Germany

For stem cells 'the process is the product,' says Pluristem

19-Apr-2017 - Manufacturing tweaks have severe effects on the quality and yield of stem cells, says Pluristem which has successfully scaled-up production through a decade of process development evolution.

Sumitomo Dainippon buys cell therapy processing tech from Hitachi

10-Apr-2017 - Sumitomo Dainippon Pharma Co Ltd has ordered cell culture technologies from Hitachi as part of its effort to develop a treatment for Parkinson’s disease.

News in brief

Permira to buy Lyophilization Services of New England

28-Mar-2017 - Private equity fund Permira has announced its intention to buy freeze drying firm Lyophilization Services of New England Inc (LSNE) 

Mylan confirms plan to close Meda Soma plant in Illinois

28-Mar-2017 - Mylan will close a manufacturing site in Decatur, Illinois that it gained when it bought Swedish drug maker Meda last year.

Lilly: Tax reforms would release $150m to further support US manufacturing

27-Mar-2017 - Eli Lilly will invest $850m in its US operations this year but warns the country’s antiquated tax system leaves the firm at a competitive disadvantage.

Eurofins pumping $5m into a UK biopharmaceutical testing site

24-Mar-2017 - Eurofins will expand its UK biopharmaceutical testing offering through a £4m ($5m) facility in Livingston, Scotland.

News in brief

German Merck taps up cell-based pyrogen detection kit

21-Mar-2017 - Solvias has struck a deal with Germany’s Merck to supply a monocyte activation test (MAT) kit for detecting pyrogens in pharmaceutical raw ingredients.

Novartis unit to consolidate Slovenian logistics in Kuehne + Nagel deal

13-Mar-2017 - Novartis subsidiary Lek Pharmaceuticals will consolidate its Slovenian logistics and warehousing operations from 10 sites to one.

Apotex expanding US footprint with $184m investment

09-Mar-2017 - Generics maker Apotex will construct a manufacturing and packaging facility as part of a $184m US expansion.

News in brief

Merck KGaA's Allergopharma opens production facility

06-Mar-2017 - Merck KGaA has opened a €42m production facility in Reinbek near Hamburg, Germany.

Keryx: Patheon and Norwich sites will ensure supply of iron-based Auryxia

06-Mar-2017 - Keryx Biopharmaceuticals will continue to work with Norwich Pharmaceuticals despite bringing Patheon on board to manufacture Auryxia (ferric citrate).

Allergan's €42m investment boosts Irish manufacturing and jobs

02-Mar-2017 - Allergan has committed €42m ($44m) to increase capacity and capabilities at two manufacturing facilities in Ireland.

Cardboard and brown agglomerates: FDA slams Pfizer injectables plant

01-Mar-2017 - Particulate problems in sterile injectables and poor aseptic techniques landed Pfizer with a US FDA warning letter at a former Hospira facility in Kansas.

Bio CDMO space: Fujifilm looking to challenge Lonza and B-I

28-Feb-2017 - Fujifilm has separated its biopharmaceutical contracting business in an effort to triple its revenues to ¥100bn ($890m) within seven years.

Looking to gain a foothold in Ireland? MSD puts shuttered site up for sale

28-Feb-2017 - Merck & Co. has put an Irish small molecule plant up for sale after ceasing production late last year.

GSK: Costa Rican Panadol plant closure will eliminate 60 jobs

27-Feb-2017 - GSK says the closing of its Costa Rica manufacturing facility is necessary to ensure the long-term viability of its consumer healthcare business.

Momenta says Pfizer will fix plant but reiterates that Glatopa 40mg ANDA delay likely

22-Feb-2017 - Momenta Pharmaceuticals has reiterated its belief that problems at a US Pfizer plant mean the FDA is unlikely to reach a decision on its 40mg version of Teva’s Copaxone before April.

Is the return of the one-stop-shop model just a CMO marketing ploy?

16-Feb-2017 - End-to end service offerings are a differentiator within the fragmented CMO industry and not driven by pharma demand, a Results Healthcare report says.

Quotient buys QS Pharma in latest US expansion move

15-Feb-2017 - Quotient Clinical Ltd. has bought Charles River Laboratories’ contract manufacturing business, QS Pharma LLC.

Thermo Fisher bags single-use bioreactor tech partner Finesse

14-Feb-2017 - Thermo Fisher Scientific says it is buying Finesse Solutions, its long-term supplier of measurement and control solutions for bioprocessing applications.

Symbiosis opens US sales office citing demand from resurgent biotechs

13-Feb-2017 - Symbiosis has opened an office in Boston, Massachusetts citing growing demand for vial filling services for highly potent APIs and large molecule injectable formulations.

GSK on America First: US will not be able to own every part of supply chain

13-Feb-2017 - GSK has warned that Donald Trump’s plan to encourage US drug production through import tax hikes must take the global nature of pharma supply chains into account.

Atlas to invest in extra capacity at STI test manufacturing partner Bespak

13-Feb-2017 - Atlas Genetics has said it will expand manufacturing capacity for cartridge-based STI tests at a UK facility owned by drug delivery technology firm Bespak Europe ltd.

GEA takes €18m hit from 'unexpected' pharma cancellation in 2016

08-Feb-2017 - Sales within the pharma division of German engineering firm GEA were down in 2016, partly due to an unexpected €18m contract cancellation.

Catalent confident it has US capacity to respond to Trump's border tax

07-Feb-2017 - Catalent says it is prepared to take on additional capacity in the US in response to a proposed border tax.

Key Industry Events

CPhI North America

Philadelphia, PA, USA / Conference and exhibition

Read more

Access all events listing